Overview
Medical device companies are expected to realign their business structures and strategies to compete in the changing global environment (such as growth of emerging markets, health care reform and cost containment). Anticipated changes include company restructuring as well as an increased reliance on strategic alliances and outsourcing for marketing, distribution, research and manufacturing activities. In this context, FinEmergia, which has been providing company and financial information globally since two decades, brings out Global Medical Devices: Quarterly Investments Review report for global medical devices/technology/supplies companies.

Objective
The objective of this quarterly investments review report is to list out the expected direction that the investments in the global medical devices/technology/supplies industry will take in the coming months of 2015. The report covers various analytical issues such as investments by sub-industries, investment strategies applied by global medical devices/technology/supplies companies, preferred locations for investments, and so on. Such trends will facilitate better investment decisions.

Research Methodology
Our research team continuously updates news from established news portals, regional and international primary news sources, business media sites, company websites, and stock exchanges. At the end of each quarter, those 400 transactions that have played a crucial role in global medical devices/technology/supplies business are identified, segregated and analyzed to highlight the various investment aspects. These are further micro-analyzed to come to a reasonably accurate conclusion on the future trends in global medical devices/technology/supplies business scenario.

• A guidance business tool which helps the investors in the global medical devices/technology/supplies industry to assess the investment opportunities for the coming months
• Helps the investors to familiarize with the existing investment trends in the global medical devices/technology/supplies industry
• Presents the key investment strategies applied by the global medical devices/technology/supplies companies
• Helps the global medical devices/technology/supplies companies to know the prevailing sub-industry trends in the global medical devices/technology/supplies business transactions
• Highlights the favored countries for the deals by the global medical devices/technology/supplies companies
• Provides useful information on regulatory authorities’ activities to accelerate global medical devices/technology/supplies business
• Summarizes the recent regulatory approvals that are likely to affect the global medical devices/technology/supplies industry
• Summarizes new policies in global medical devices/technology/supplies sector and its impact globally
• Provides at one glance the listing of global medical devices/ technology/supplies companies covered

• 1.1.1 Most preferred investment strategies
• 1.1.2 Key research and development activities: an analysis
• 1.1.3 Key contracts/deals: an analysis
• 1.1.4 Key mergers and acquisitions: an analysis
• 1.1.5 Key joint ventures: an analysis
• 1.1.6 Key expansions: an analysis

• 1.2.1 Sub-industries where most transactions took place
• 1.2.2 Most preferred countries for each sub-industry
• 1.2.3 Top 5 companies for each sub-industry

• 1.3.1 Top 10 countries where most transactions took place
• 1.3.2 Sub-industry wise transactions in these countries

• 2.1 Regulatory authorities most in news
• 2.2 Some recent regulatory authorities’ activities
• 2.3 Some recent regulatory approvals

• 3.1 Few recent important policies globally
• 3.2 Impact of such policies

• 4.1 Comparison with previous quarter
• 4.2 Expected trends in coming months of 2015

• List of global medical devices/technology/supplies companies covered: By region, country, and company name

• Simavita Ltd (Australia)
• Solborn Incorporated (South Korea)
• Sorin SpA (Italy)
• Strand Life Sciences Private Limited (India)
• Stratec Biomedical AG (Germany)
• Straumann Holding AG (Switzerland)
• Sunshine Holdings PLC (Sri Lanka)
• Sysmex Corporation (Japan)
• Thermo Fisher Scientific Inc (United States)
• Tornier NV (Netherlands)
• Toumaz Limited (United Kingdom)
• TSO3 Inc (Canada)
• Varian Medical Systems, Inc. (United States)
• Vivoline Medical AB (Sweden)
• Voxel SA (Poland)
• William Demant Holding (Denmark)
• Wound Management Technologies, Inc. (United States)
• Yamato Scientific Co, Ltd (Japan)
• Zecotek Photonics Inc (Canada)
• Zhejiang DA Diagnostics Co Ltd (China)

• Company news analysts with years of experience analyze business transactions and investment trends for global medical devices/technology/supplies industry
• The report is useful to Business Development Executives in assessing the business propositions of the global medical devices/technology/supplies industry for following-up with business opportunities for their companies
• The report is useful to Project Analysis Departments in analyzing the global medical devices/technology/supplies business transactions data for preparing their future plans
• The report is useful to the medical devices/technology/supplies dedicated Regulatory Authorities in equipping with the present industry trends/analysis to accelerate the business
• The report is useful to Investors by revealing the emerging and vibrant investment trends for the global medical devices/technology/supplies industry

Subscription Fees:

• $200 per Report
• $650 /Annual for 4 quarters
• $1,650 for annual subscriptions of three Global Medical Devices - Investment Analysis publications - savings of $550.

To order, please visit FinGlobeDirect InfoStore at http://www.finglobedirect.com/index.php/global-medical-devices-infostore

Please send us an email for any further queries to info@finemergia.com